ADROAduro Biotech

$3.05
$0.08 (3%)

Aduro Biotech (ADRO) Stock Analysis

Create a FREE Account to View Full ADRO Stock Report

Aduro Biotech (ADRO) Analyst Forecast

Next 12 months ➝Current Price$3.0552-week High$4.5952-week Low$0.90MEAN$6.00+96.72%HIGH$8.00+162.30%LOW$4.00+31.15%
  • Last Price$3.05
  • Previous Close$2.97
  • Change $0.08
  • Open$2.58
  • Volume1,257,435
  • Avg. Volume (100-day)1,128,458
  • Market Capitalization$245.57M
  • Days Range $2.55 - $3.08
  • 52-week Range $0.90 - $4.59
  • Dividend Yield
  • Ex. Dividend Date
  • P-E
  • EPS-1.11
  • Earnings Date05/26/2020
  • SectorHealthcare
  • IndustryBiotechnology
  • Avg. Analyst Rec.
  • Beta2.678
  • PEG Ratio
  • Volatility0.89
  • Average True Range0.09
Aduro Biotech Inc is a immunotherapy company focused on the discovery, development and commercialization of therapies that are designed to harness the body's natural immune system for the treatment of patients with challenging diseases. Its primary technologies related are to the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand. The STING pathway activator technology is designed to activate the intracellular STING receptor. The APRIL is a soluble factor that binds to BCMA and TACI receptors thereby inducing signaling, and is implicated in IgA nephropathy.